[1] XIA C,DONG X,LI H,et al.Cancer statistics in China and United States,2022:profiles,trends and determinants[J].Chin Med J(Engl),2022,135(5):584-590.
[2] LI P,JING J,RUI L,et al.Upper gastrointestinal cancer in China:Spatial epidemiologic evidence from screening areas[J].Cancer Prev Res(Phila),2020,13(11):935-946.
[3] 乔友林.食管癌流行病学研究的重要里程碑[J].中国肿瘤临床,2016,43(12):500-501.
QIAO YL.An important milestone in the epidemiology of esophageal cancer[J].Chinese Journal of Clinical Oncology,2016,43(12):500-501.
[4] 王鑫,肖泽芬.老年食管癌的治疗选择[J].中华放射肿瘤学杂志,2018,27(10):941-944.
WANG X,XIAO ZF.Treatment options for esophageal cancer in the elderly patients[J].Chinese Journal of Radiation Oncology,2018,27(10):941-944.
[5] 章文成,庞青松.老年食管癌的放射治疗研究进展[J].中国肿瘤临床,2018,45(24):1272-1276.
ZHANG WC,PANG QS.Progress in radiotherapy for esophageal carcinoma in elderly patients[J].Chinese Journal of Clinical Oncology,2018,45(24):1272-1276.
[6] YEFIM MANEVICH,ARON B FISHER.Peroxiredoxin 6,a 1-Cys peroxiredoxin,functions in antioxidant defense and lung phospholipid metabolism[J].Free Radic Biol Med,2005,38(11):1422-1432.
[7] JHANG HO PAK,WON HO CHOI,HYE MI LEE.Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells[J].Cancer Invest,2011,29(1):21-28.
[8] HYUNG MUN YUN,KYUNG RAN PARK,MI HEE PARK,et al.PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model[J].Free Radic Biol Med,2015,80:p.136-144.
[9] SAMI RAATIKAINEN,SIRPA AAALTOMAA,VESA KARJA,et al.Increased peroxiredoxin 6 expression predicts biochemical recurrence in prostate cancer patients after radical prostatectomy[J].Anticancer Res,2015,35(12):6465-6470.
[10] ARON B FISHER.Peroxiredoxin 6:a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities[J].Antioxid Redox Signal,2011,15(3):831-844.
[11] HUANG WS,HUANG CY,MENG CHIAO HESIEH,et al.Expression of PRDX6 correlates with migration and invasiveness of colorectal cancer cells[J].Cell Physiol Biochem,2018,51(6):2616-2630.
[12] HU XL,LU E,PAN CY,et al.Overexpression and biological function of PRDX6 in human cervical cancer[J].J Cancer,2020,11(9):2390-2400.
[13] JIN NYOUNG HO,SEUNG BUM LEE,SEUNG SOOK LEE,et al.Phospholipase A2 activity of peroxiredoxin 6 promotes invasion and metastasis of lung cancer cells[J].Mol Cancer Ther,2010,9(4):825-832.
[14] CHANG XZ,LI DQ,HOU YF,et al.Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer[J].Breast Cancer Res,2007,9(6):R76.
[15]NOOROLYAI S,SHAJARI N,BAGHBANI E,et al.The relation between PI3K/AKT signalling pathway and cancer[J].Gene,2019,698:120-128.
[16] ISABELL GOETTING,SAFA LARAFA,KATHARINA EUL,et al.Targeting AKT-dependent regulation of antioxidant defense sensitizes AKT-E17K expressing cancer cells to Ionizing radiation[J].Frontiers in Oncology,2022,12:1-15.
[17] LARIONOVA I,RAKINA M,LVANYUK E,et al.Radiotherapy resistance:identifying universal biomarkers for various human cancers[J].Journal of Cancer Research and Clinical Oncology,2022,148(5):1015-1031.